News and Announcements
Kinesis are proud to present their Minimum Viable Product (MVP) demo
- Published November 05, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Kinesis Monetary System are proud to present the walkthrough guide of their Minimum Viable Product (MVP) demo.
- The Kinesis MVP allows gold and silver to be traded for everyday use.
- The demo allows users to create their own eWallets mint their own Kinesis currencies
Kinesis Monetary System are proud to present the walkthrough guide of their Minimum Viable Product (MVP) demo.
The MVP demo of the Kinesis Currency Exchange (KCX) and the Kinesis eWallet is available for customers to explore and test.
The Kinesis MVP allows gold and silver to be traded for everyday use.
The demo allows users to create their own eWallets mint their own Kinesis currencies (KAU = gold and KAG = silver) through the KCX, emit these currencies into their wallets and then send the currencies to other Kinesis eWallets on the Kinesis Blockchain.
The demo can be accessed here.
About Kinesis Monetary System
The vision for Kinesis is to deliver an evolutionary step beyond any monetary system available today. This is achieved by basing the Kinesis currencies 1:1 on allocated physical gold and silver. Use is incentivised by attaching a unique yield system to the Kinesis currencies and distributing back the wealth generated according to proportionate currency holdings and velocity.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
